PRLD Latest Press Releases

-- October 16, 2026 --

Prelude Therapeutics to Participate in the Chardan Healthcare Conference Globe Newswire 4:01 PM

-- October 13, 2026 --

Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio and Inluriyo in Patients with HR+/HER2- Breast Cancer Globe Newswire 7:01 AM

-- September 11, 2026 --

Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 7:01 AM

-- September 10, 2026 --

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader Globe Newswire 7:01 AM

-- August 11, 2026 --

Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes